Skip to main content
Premium Trial:

Request an Annual Quote

José Baselga, Brook Byers, Kaye Foster

Grail has appointed José Baselga, Brook Byers, and Kaye Foster to its board of directors. They will join currently serving board members Bill Rastetter, Jeff Huber, Richard Klausner, and Robert Nelsen. Baselga is the physician-in-chief and chief medical officer at Memorial Sloan Kettering Cancer Center, and professor of medicine at Weill Cornell Medical College. He also serves as the chairman of Grail's Scientific Advisory Board. Byers is a senior partner and founding member of Kleiner Perkins Caufield & Byers (KPCB). Foster currently advises CEOs and leadership teams focusing on business transformations, talent management strategy, and human resources strategy development and implementation. She most recently served as senior VP of Global Human Resources for Onyx Pharmaceuticals.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.